S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, & V. O. Smirnova. (2019). Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria. IRBIS LLC.
Chicago Style (17th ed.) CitationS. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, and V. O. Smirnova. Pharmacoeconomic Analysis of Ceftazidime+avibactam (Zavicefta®) in the Treatment of Sepsis Caused by Carbapenem-resistant Enterobacteria. IRBIS LLC, 2019.
MLA (9th ed.) CitationS. V. Nedogoda, et al. Pharmacoeconomic Analysis of Ceftazidime+avibactam (Zavicefta®) in the Treatment of Sepsis Caused by Carbapenem-resistant Enterobacteria. IRBIS LLC, 2019.
Warning: These citations may not always be 100% accurate.